ALCMI’s GOYLC study has been published in JTO Clinical and Research Reports. Click here to read the full text article.
ALCMI’s GOYLC study has been published in JTO Clinical and Research Reports. Click here to read the full text article.
Study will evaluate the use of a blood-based biomarker to predict outcomes in high PD-L1 expressing non-small cell lung cancer patients treated with immune checkpoint inhibitors plus or minus chemotherapy